title: Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
authors.affiliation: Institute of Hematology, University of Perugia, Ospedale S. Maria della Misericordia, S. Andrea delle Fratte, Perugia, Italy. faliniem@unipg.it
authors.forename: Brunangelo
authors.initials: B
authors.lastname: Falini
authors.forename: Maria Paola
authors.initials: MP
authors.lastname: Martelli
authors.forename: Niccolò
authors.initials: N
authors.lastname: Bolli
authors.forename: Paolo
authors.initials: P
authors.lastname: Sportoletti
authors.forename: Arcangelo
authors.initials: A
authors.lastname: Liso
authors.forename: Enrico
authors.initials: E
authors.lastname: Tiacci
authors.forename: Torsten
authors.initials: T
authors.lastname: Haferlach
mesh_terms: D000818:Animals; D018703:Founder Effect; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000145:classification* / Q000175:diagnosis / Q000235:genetics*; D008954:Models, Biological; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D009154:Mutation / Q000502:physiology; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D000090243:Nucleophosmin; D011379:Prognosis
chemical_list: D050505:Mutant Proteins; C000716967:NPM1 protein, human; D009687:Nuclear Proteins; D000090243:Nucleophosmin